Medical News

RSS

Amgen announces positive results for Denosumab postmenopausal osteoporosis trial

Amgen has announced findings from the pivotal fracture trial evaluating its RANK Ligand inhibitor, denosumab, in the treatment of postmenopausal osteoporosis.

27 Jul 2008

NIDDK publishes strategic plan for research into benign prostate

For the first time, a strategic plan for research into benign prostate disease, based on the latest scientific knowledge, has been published by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH). The NIDDK Prostate Research Strategic Plan is the culmination of discussions and meetings among experts over the past two years in an effort to outline a strategic vision for research into these elusive and multi-faceted diseases.

27 Jul 2008

Researchers disprove long-standing belief about HIV treatment

Researchers at Wake Forest University Baptist Medical Center have disproved a long-standing clinical belief that the hepatitis C virus slows or stunts the immune system's ability to restore itself after HIV patients are treated with a combination of drugs known as the 'cocktail.'

27 Jul 2008

Antimicrobial sutures reduce infections in brain shunt surgery

Children born with hydrocephalus, or "water on the brain" must have shunts implanted to drain the fluid away from the brain to reduce harmful pressure.

27 Jul 2008

Hey fever! The surprise benefit of allergies

Long-suffering victims of allergies such as asthma and hay fever might enjoy a surprise benefit, according to research led by the University of New South Wales (UNSW).

24 Jul 2008

Chemo and radiation after surgery prolongs life for pancreatic cancer patients

Pancreatic cancer patients treated with a combination of chemotherapy and radiation after surgery survive approximately six months longer than those receiving surgery alone, Johns Hopkins Kimmel Cancer Center scientists report.

24 Jul 2008

Soyfoods Association response to research on soy in men

Headlines claiming "soy products lower sperm count" do not tell the whole story. The small scale, preliminary study that Dr. Jorge Chavarro, published online in Human Reproduction, is based on recollected intake of soyfoods and not on specific diets containing soyfoods.

24 Jul 2008

Barr confirms Fentora tablet patent challenge

Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Cephalon, Inc. in connection with its Fentora(R) Tablets (fentanyl citrate buccal tablets), equivalent to fentanyl base 100 mcg, 400 mcg, 600 mcg and 800 mcg.

24 Jul 2008

Hyperactive immune resistance brings blindness in old age

Age-dependent macular degeneration (AMD) is the commonest cause of blindness in the western industrialised nations. Hereditary changes in the regulation of the immune system influence the risk of contracting AMD.

24 Jul 2008

Allergic rhinitis diagnosis and treatment: new guidelines for primary care professionals

Two complementary guidelines on the diagnosis and treatment of allergic rhinitis are published in the August issue of the Allergy journal.

24 Jul 2008

Xylitol 'gummy bears' may prevent dental problems

The tooth-protecting sugar substitute xylitol has been incorporated into gummy bears to produce a sweet snack that may prevent dental problems.

24 Jul 2008

Suprising finding on aging

Age may not be rust after all. Specific genetic instructions drive aging in worms, report researchers at the Stanford University School of Medicine. Their discovery contradicts the prevailing theory that aging is a buildup of tissue damage akin to rust, and implies science might eventually halt or even reverse the ravages of age.

24 Jul 2008

Congress approves global AIDS bill which will save millions of lives

AIDS Healthcare Foundation (AHF) lauded the U.S. House of Representatives for passing legislation (today's House vote to concur on the Senate amended House PEPFAR bill: 303 to 115) re-authorizing PEPFAR (the President's Emergency Plan for AIDS Relief), the successful US global AIDS program.

24 Jul 2008

U.S. authorities seize Xiadafil VIP tablets after company refuses to recall product

At the request of the U.S. Food and Drug Administration, U.S. Marshals seized nearly $74,000 worth of Xiadafil VIP tablets, Lots 6K029 and 6K209-SEI, distributed by SEI Pharmaceuticals, Inc. of Miami, Fla. Although marketed as a dietary supplement to treat erectile dysfunction (ED) and for sexual enhancement, these lots represent an illegally marketed drug containing an undeclared ingredient.

24 Jul 2008

A dangerous precedent in HIV

Infection with HIV could quadruple in certain populations if people with HIV follow potentially misleading advice contained in a statement from the Swiss Federal Commission for HIV/AIDS, University of New South Wales (UNSW) research warns.

24 Jul 2008

Study shows emergency physicians have good first instincts in diagnosing heart attacks

A study out of Wake Forest University Baptist Medical Center demonstrates emergency room doctors are correctly identifying patients who are having a heart attack, even when laboratory tests haven't yet confirmed it.

24 Jul 2008

Energy drinks associated with risk-taking behaviors among college students

Over the last decade, energy drinks -- such as Red Bull, Monster and Rockstar -- have become nearly ubiquitous on college campuses. The global market for these types of drinks currently exceeds $3 billion a year and new products are introduced annually.

24 Jul 2008

Life expectancy of HIV patients increases

HIV-infected patients in high income countries are living some 13 years longer thanks to improvements in combination antiretroval therapy (cART), according to new research by the University of Bristol published in a HIV Special Issue of The Lancet today.

24 Jul 2008

Researchers find key mechanism of cell damage in aging and disease

Researchers have taken a first snapshot of how a class of highly reactive molecules inflicts cellular damage as part of aging, heart disease, stroke, cancer, diabetes, kidney disease and Alzheimer's disease to name a few. According to a study published today in the journal Cell, researchers have discovered a tool that can monitor related damage and determine the degree to which antioxidant drugs effectively combat disease.

24 Jul 2008